Moreover, whether the methylation frequency of DAPK promoter is correlated with clinicopathological features (sex, smoking status, alcohol status and lymph node invasion) in HNSCC patients remains unclear. Here, DAPK1 is linked to head and neck squamous cell carcinoma.